by Thomas Agrait | Jan 30, 2019 | Business Decision Making, Business Transformation, Collaboration, Commitment, Communication, Connection, Creativity, Curiosity, Efficiency, Emotional Intelligence, Energy, Engineering, Hospitality Business, Human Error, Imagination, Improvement, Innovation, Interaction, Mindfulness, Motivation, Networking Event, Neural Networks, Neuro-Linguistic Programming, NeuroGneering, Neuroscience, People Engagement, Personal Development & Improvement, Process Improvement, Professional Development, Profitability, prosperous, Respect, Social Responsibility, Team Work, Wealth
...
by Thomas Agrait | Jan 30, 2019 | Business Transformation, Collaboration, Commitment, Communication, Computational Neuroscience, Connection, Creativity, Curiosity, Efficiency, Emotional Intelligence, Energy, Gratitude, Human Error, Imagination, Improvement, Innovation, Leadership, Love & Compasion, Mindfulness, Motivation, Networking Event, Neural Networks, Neuro-Linguistic Programming, NeuroGneering, Neuroscience, prosperous, Wealth
VORTEX, the NeuroGneering division of Lean Enterprise Consulting in Buenos Aires, Argentina. To all our friends in Argentina, the “Neuroscience Tools for Peak Performance Teams” to be delivered by the end of April 2019 in Buenos Aires is already sold out...
by Thomas Agrait | Jan 22, 2019 | cGMP, Communication, Compliance, Engineering, FDA New Guidelines, Guidelines, Job Opportunities, Manufacturing, Pharma, Process Improvement, Professional Development, QA, Quality Systems, Risk Assessment, Tech
Our firm is searching for a Technical Writer for a pharmaceutical client located in South Florida. As a Technical Writer some of your responsibilities will be: Assessment, improvement, and standardization of business processes including...
by Thomas Agrait | Jan 22, 2019 | Business Decision Making, cGMP, Communication, Community Service, Compliance, Ethics, FDA, FDA News, Guidelines, Manufacturing, Pharma, Process Improvement, Quality Systems, Recalls, Regulatory, Risk Assessment, Uncategorized
Another voluntary recall of medications used in the treatment of high blood pressure has been issued due to the detection in the active pharmaceutical ingredient of an impurity considered probably carcinogenic to humans by the U.S. Environmental Protection Agency. To...
by Thomas Agrait | Jan 8, 2019 | Admiration, Business Transformation, Celebration, Collaboration, Commitment, Communication, Efficiency, Energy, Hospitality Business, Human Error, Imagination, Improvement, Innovation, Mindfulness, Motivation, Networking Event, NeuroGneering, People Engagement, Personal Development & Improvement, Profitability, Quality Systems, Wealth
...
Recent Comments